蛋白酶体
蛋白质聚集
泛素
细胞生物学
热休克蛋白
化学
小分子
伴侣(临床)
生物物理学
生物
生物化学
基因
医学
病理
出处
期刊:Springer eBooks
[Springer Nature]
日期:2021-01-01
卷期号:: 277-285
标识
DOI:10.1007/978-1-0716-1441-9_16
摘要
AbstractThere are increasing evidence and growing interest in the relationship between protein aggregates/phase separation and various human diseases, especially neurodegenerative diseases. However, we do not entirely comprehend how aggregates generate or the clearance network of chaperones, proteasomes, ubiquitin ligases, and other factors interact with aggregates. Here, we describe chemically controllable systems compose with a genetically engineered cell and a small drug that enables us to rapidly induce protein aggregates’ formation by withdrawing the small molecule. This trigger does not activate global stress responses induced by stimuli, such as proteasome inhibitors or heat shock. This method can produce aggregates in a specific compartment and diverse experimental systems, including live animals.Key words Chemical biology Protein aggregates Chaperones Proteasome Destabilizing domain Phase separation
科研通智能强力驱动
Strongly Powered by AbleSci AI